• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RAYNER INTRAOCULAR LENSES LIMITED RAYONE SPHERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RAYNER INTRAOCULAR LENSES LIMITED RAYONE SPHERIC Back to Search Results
Model Number RAO100C
Device Problem Material Opacification (1426)
Patient Problem Visual Impairment (2138)
Event Date 09/09/2023
Event Type  malfunction  
Event Description
On 13th september 2023, rayner received notification from an indian healthcare facility of an event that occurred following implantation of a rayone spheric rao100c.The event description provided states that opacification of the iol was observed 15 days post-operatively.
 
Manufacturer Narrative
The reference (b)(4) has been allocated to this case by rayner.The event description provided states that 15 days post-operatively the patient presented with iol opacification.The patient's vision is reported as 6/12p.Given the short time between surgery and the observation being made, it is possible to consider a number of potential causes which could be explored; the main candidates being pco, capsular block (from any residual ovd left behind the lens taking on water and swelling, becoming cloudy and forcing the lens out of position) and fibrin reaction.The timing of onset is quite soon for a potential posterior capsule opacification (pco) case as this is more usually noted in the 2 to 5 year date range after implantation due to the slow growth rate of lecs.This also applies to typical cases of post-operative opacification or calcification (whereby calcium phosphate deposits are identified on the lens via scanning electron microscopy analysis).There are certain patient conditions that may increase the likelihood of deposits developing within the eye post-operatively including but not limited to; glaucoma, diabetes, pseudoexfoliation syndrome.Secondary calcification affects many manufacturers and is a phenomenon that is not fully understood; it is known that it stems from changes in the eye's environment due to patient comorbidity, secondary surgeries and potentially other, poorly understood interactions: off label use of intracameral alteplase (actilyse) (rtpa), multifactorial, high phosphate content ophthalmic viscoelastic devices , repeated exposure to intracameral air, raised intraocular pressure, excessive post-operative inflammation, complicated, traumatised eyes, as a result of direct contact between the iol surface and the exogenous gas or substance, a metabolic change in the anterior chamber due to the presence of exogenous gas/substance in the eye or an exacerbated inflammatory reaction after multiple surgical procedures, trauma or repeat surgery involved in re-bubbling potentially disrupting the blood aqueous barrier, increasing concentration of calcium ions.Rayner has contacted the reporting healthcare professional to obtain additional information to facilitate further investigation of the event.Our review of production records for the rayone spheric rao100c batch 013208088 showed that all manufacturing and quality checks were conducted with successful results.All devices released for distribution from this batch were within tolerance, met specification criteria and were without defects.A review of existing vigilance data confirms that this is an isolated event.This review concluded that no other incidents, of any type, have been received against the rayone spheric rao100c batch 013208088.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RAYONE SPHERIC
Type of Device
RAYONE SPHERIC
Manufacturer (Section D)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK  BN14 8AQ
Manufacturer (Section G)
RAYNER INTRAOCULAR LENSES LIMITED
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 8AQ
UK   BN14 8AQ
Manufacturer Contact
jodie neal
the ridley innovation centre
10 dominion way
worthing, west sussex BN14 -8AQ
UK   BN14 8AQ
MDR Report Key17833599
MDR Text Key324462968
Report Number3012304651-2023-00117
Device Sequence Number1
Product Code HQL
UDI-Device Identifier05029867690662
UDI-Public(01)05029867690662
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P060011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 09/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberRAO100C
Device Catalogue NumberRAO100C
Device Lot Number013208088
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/29/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age60 YR
Patient SexFemale
-
-